Cargando…

Targeted treatment of chronic myeloid leukemia: role of imatinib

Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by clonal expansion of pleuripotent hematopoetic stem cells. The incidence of CML is 1 to 2 cases per 100,000 people per year; in the Western Hemisphere, CML accounts for 15% of leukemias in adults. Discovery of the specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamascar, Ila, Ramanarayanan, Jeyanthi
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886320/
https://www.ncbi.nlm.nih.gov/pubmed/20616895